XML 21 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities    
Net income $ 91,783 $ 125,438
Adjustment to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 80,061 70,655
Amortization of contract acquisition costs 1,345 575
Amortization of debt issuance costs 735 719
Imputed interest expense and fair value adjustments to contingent consideration, net 2,070 1,046
Provision for credit losses 1,561 (34)
(Gain) loss on disposal of assets 1,587 524
Impairment losses 13,299 3,949
Deferred income taxes (8,216) 514
Excess tax benefit from equity-based awards (1,256) (5,284)
Equity-based compensation expense 13,240 11,969
(Gain) loss on foreign currency derivatives $ 269 $ 134
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Other nonoperating income expense Other nonoperating income expense
Changes in assets and liabilities, net of acquisitions:    
Accounts receivable $ (37,987) $ 48,816
Prepaids and other assets 38,594 (42,455)
Accounts payable and accrued expenses 1,483 19,406
Deferred revenue and other liabilities (79,755) (60,910)
Net cash provided by operating activities 118,813 175,062
Cash flows from investing activities    
Proceeds from sale of long-live assets 189 42
Purchases of property, plant and equipment (64,564) (40,778)
Acquisitions, net of cash acquired of zero and $18,638, respectively (142,420) (481,718)
Net cash used in investing activities (206,795) (522,454)
Cash flows from financing activities    
Net proceeds (borrowings) from line of credit 164,000 420,000
Payments on other debt (2,568) (5,288)
Payments of contingent consideration and hold back payments to acquisitions (9,600) (11,517)
Dividends paid to shareholders (23,518) (20,132)
Payments to noncontrolling interest (9,562) (8,059)
Tax payments related to issuance of restricted stock units (6,980) (11,369)
Payments of debt issuance costs 0 (1,102)
Net cash (used in) provided by financing activities 111,772 362,533
Effect of exchange rate changes on cash, cash equivalents and restricted cash (22,226) (6,272)
Increase (decrease) in cash, cash equivalents and restricted cash 1,564 8,869
Cash, cash equivalents and restricted cash, beginning of period 180,682 159,015
Cash, cash equivalents and restricted cash, end of period 182,246 167,884
Supplemental disclosures    
Cash paid for interest 19,699 7,827
Cash paid for income taxes 32,705 64,999
Non-cash investing and financing activities    
Acquisition of long lived assets through finance leases 461 857
Acquisition of equipment through increase in accounts payable, net 6,625 130
Dividends declared but not paid $ 24,554 $ 22,085